粒细胞肉瘤6例
6 Cases of Granulosa Sarcoma
DOI: 10.12677/ACM.2020.107189, PDF,   
作者: 王诗梦：青岛大学，山东 青岛；吴 颖, 王 伟*：青岛大学附属医院血液内科，山东 青岛
关键词: 粒细胞肉瘤；诊断；鉴别诊断；治疗；预后；急性髓系白血病；Granulocytic Sarcoma； Diagnosis； Differential Diagnosis； Treatment； Prognosis； Acute Myeloid Leukemia
摘要: 目的：探讨粒细胞肉瘤(Granulocytic Sarcoma; GS)的诊断、鉴别诊断及治疗。方法：回顾性分析青岛大学附属医院自2000年6月至2019年6月收治的6例GS的临床资料中，男2例，女4例，中位年龄51.7岁(37~66岁)，其中孤立性粒细胞肉瘤5例，髓外浸润性粒细胞肉瘤1例，讨论其临床病理特征、诊断及治疗。结果：6例GS临床表现多样，首发表现为肿物伴或者不伴有疼痛，免疫组化MPO、CD68、CD113、CD117等阳性率较高，治疗上以联合化疗为主。结论：GS临床误诊率很高，免疫组化具有特异性，易转化为急性髓系白血病，预后差。
Abstract: Objective: To explore the diagnosis, differential diagnosis and treatment of granulocytic sarcoma (GS). Methods: Retrospective analysis of the clinical data of 6 cases of GS admitted to the Affiliated Hospital of Qingdao University from June 2000 to June 2019, including 2 males and 4 females, with a median age of 55 years (37 - 66 years), including isolation. There were 5 cases of granulosa sarcoma and 1 case of extramedullary infiltrating granulosa sarcoma. The clinicopathological characteristics, diagnosis and treatment were discussed. Results: Six cases of GS have various clinical manifestations, the first manifestation is tumor with or without pain, and the immunohistochemical MPO, CD68, CD113, CD117 and other positive rates are high, the main treatment is combined chemotherapy. Conclusion: The clinical misdiagnosis rate of GS is very high, immunohistochemistry is specific, it is easy to be transformed into acute myeloid leukemia, and the prognosis is poor.
文章引用：王诗梦, 吴颖, 王伟. 粒细胞肉瘤6例[J]. 临床医学进展, 2020, 10(7): 1239-1245. https://doi.org/10.12677/ACM.2020.107189

参考文献

[1] Sabattini, E., Bacci, F., Sagramoso, C., et al. (2010) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues in 2008: An Overview. Pathologica, 102, 83-87.
[2] Kaur, V., Swami, A., Alapat, D., et al. (2018) Clinical Characteristics, Molecular Profile and Outcomes of Myeloid Sarcoma: A Single Institution Experience over 13 Years. Hematology, 23, 17-24. [Google Scholar] [CrossRef] [PubMed]
[3] Almond, L.M., Charalampakis, M., Ford, S.J., et al. (2017) Myeloid Sarcoma: Presentation, Diagnosis, and Treatment. Clinical Lymphoma, Myeloma & Leukemia, 17, 263-267. [Google Scholar] [CrossRef] [PubMed]
[4] Campidelli, C., Agostinelli, C., Stitson, R., et al. (2009) Myeloid Sarcoma: Extramedullary Manifestation of Myeloid Disorders. American Journal of Clinical Pathology, 132, 426-437. [Google Scholar] [CrossRef] 
[5] Peloquin, G.L., Chen, Y.-B. and Fathi, A.T. (2013) The Evolving Landscape in the Therapy of Acute Myeloid Leukemia. Protein & Cell, 4, 735-746. [Google Scholar] [CrossRef] [PubMed]
[6] Pui, M.H., Fletcher, B.D. and Langston, J.W. (1994) Granulocytic Sarcoma in Childhood Leukemia: Imaging Features. Radiology, 190, 698-702. [Google Scholar] [CrossRef] [PubMed]
[7] Singh, A., Kumar, P., Chandrashekhara, S.H., et al. (2017) Unravelling Chloroma: Review of Imaging Findings. The British Journal of Radiology, 90, 20160710. [Google Scholar] [CrossRef] [PubMed]
[8] Kamboj, M., Sharma, A., Gupta, G., et al. (2017) Isolated Myeloid Sarcoma of Cervix: Aleukemic Presentation. Journal of Cancer Research and Therapeutics, 13, 1076-1077.
[9] Claerhout, H., Van Aelst, S., Melis, C., et al. (2018) Clinicopathological Characteristics of de Novo and Secondary Myeloid Sarcoma: A Monocentric Retrospective Study. European Journal of Haematology, 100, 603-612. [Google Scholar] [CrossRef] [PubMed]
[10] Neiman, R.S., Barcos, M., Berard, C., et al. (1981) Granulocytic Sarcoma: A Clinicopathologic Study of 61 Biopsied Cases. Cancer, 48, 1426-1437. [Google Scholar] [CrossRef] 
[11] Meyer, H.-J., Beimler, M., Borte, G., et al. (2019) Radiological and Clinical Patterns of Myeloid Sarcoma. Radiology and Oncology, 53, 213-218. [Google Scholar] [CrossRef] [PubMed]
[12] Aschoff, P., Häntschel, M., Oksüz, M., et al. (2009) Integrated FDG-PET/CT for Detection, Therapy Monitoring and Follow-Up of Granulocytic Sarcoma. Initial Results. Nuklearmedizin, 48, 185-191. [Google Scholar] [CrossRef] [PubMed]
[13] Zhang, X., Huang, P., Chen, Z., et al. (2019) Vulvar Myeloid Sarcoma as the Presenting Symptom of Acute Myeloid Leukemia: A Case Report and Literature Review of Chinese Patients, 1999-2018. Diagnostic Pathology, 14, Article No.: 126. [Google Scholar] [CrossRef] [PubMed]
[14] Pileri, S.A., Ascani, S., Cox, M.C., et al. (2007) Myeloid Sarcoma: Clinico-Pathologic, Phenotypic and Cytogenetic Analysis of 92 Adult Patients. Leukemia, 21, 340-350. [Google Scholar] [CrossRef] [PubMed]
[15] Alexiev, B.A., Wang, W., Ning, Y., et al. (2007) Myeloid Sarcomas: A Histologic, Immunohistochemical, and Cytogenetic Study. Diagnostic Pathology, 2, Article No.: 42. [Google Scholar] [CrossRef] [PubMed]
[16] Bakst, R.L., Tallman, M.S., Douer, D., et al. (2011) How I Treat Extramedullary Acute Myeloid Leukemia. Blood, 118, 3785-3793. [Google Scholar] [CrossRef] [PubMed]
[17] Tsimberidou, A.-M., Kantarjian, H.M., Wen, S., et al. (2008) Myeloid Sarcoma Is Associated with Superior Event- Free Survival and Overall Survival Compared with Acute Myeloid Leukemia. Cancer, 113, 1370-1378. [Google Scholar] [CrossRef] [PubMed]
[18] Yamauchi, K. and Yasuda, M. (2002) Comparison in Treatments of Nonleukemic Granulocytic Sarcoma: Report of Two Cases and a Review of 72 Cases in the Literature. Cancer, 94, 1739-1746. [Google Scholar] [CrossRef] [PubMed]
[19] Florou, V. and Wilky, B.A. (2018) Current and Future Directions for Angiosarcoma Therapy. Current Treatment Options in Oncology, 19, Article No.: 14. [Google Scholar] [CrossRef] [PubMed]
[20] Shelley, M.D., Mason, M.D. and Kynaston, H. (2010) Intravesical Therapy for Superficial Bladder Cancer: A Systematic Review of Randomised Trials and Meta-Analyses. Cancer Treatment Reviews, 36, 195-205. [Google Scholar] [CrossRef] [PubMed]
[21] Bielack, S.S., Erttmann, R., Kempf-Bielack, B., et al. (1996) Impact of Scheduling on Toxicity and Clinical Efficacy of Doxorubicin: What Do We Know in the Mid-Nineties? European Journal of Cancer, 32A, 1652-1660. [Google Scholar] [CrossRef] [PubMed]
[22] Skubitz, K.M. and Haddad, P.A. (2005) Paclitaxel and Pegylated-Liposomal Doxorubicin Are Both Active in Angiosarcoma. Cancer, 104, 361-366. [Google Scholar] [CrossRef] [PubMed]
[23] Lan, T.-Y., Lin, D.-T., Tien, H.-F., et al. (2009) Prognostic Factors of Treatment Outcomes in Patients with Granulocytic Sarcoma. Acta Haematologica, 122, 238-246. [Google Scholar] [CrossRef] [PubMed]
[24] Chevallier, P., Mohty, M., Lioure, B., et al. (2008) Allogeneic Hematopoietic Stem-Cell Transplantation for Myeloid Sarcoma: A Retrospective Study from the SFGM-TC. Journal of Clinical Oncology, 26, 4940-4943. [Google Scholar] [CrossRef] 
[25] 林桂真. 自体与异体造血干细胞移植后造血系统重建的状况与差异分析[J]. 新医学, 2005, 36(5): 277-278.
[26] Avni, B. and Koren-Michowitz, M. (2011) Myeloid Sarcoma: Current Approach and Therapeutic Options. Therapeutic Advances in Hematology, 2, 309-316. [Google Scholar] [CrossRef] [PubMed]
[27] He, J., Zhu, L., Ye, X., et al. (2014) Clinical Characteristics and Prognosis of Nonleukemic Myeloid Sarcoma. The American Journal of the Medical Sciences, 347, 434-438. [Google Scholar] [CrossRef] 

为你推荐